EMEA (Europe, Middle East and Africa) mRNA Vaccines & Therapeutics Market Report 2017

August 2017 | 116 pages | ID: EDE6F4A4D55EN
QYResearch

Abstracts

In this report, the EMEA mRNA Vaccines & Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of mRNA Vaccines & Therapeutics for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA mRNA Vaccines & Therapeutics market competition by top manufacturers/players, with mRNA Vaccines & Therapeutics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Argos Therapeutics
• AstraZeneca
• Bayer
• BioNTech
• Boehringer Ingelheim
• CRISPR Therapeutics
• CureVac
• eTheRNA immunotherapies
• Ethris
• GlaxoSmithKline Vaccines
• In-Cell-Art
• Intellia Therapeutics
• Janssen
• Kernal Biologics
• MaxCyte
• Moderna Therapeutics
• Novartis
• PhaseRx
• Precision NanoSystems
• RaNa Therapeutics

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Standardization Of Cancer Treatment MRNA Vaccine
• Individualized Cancer Treatment MRNA Vaccine
• Infectious Disease Treatment MRNA Vaccine
• Infection Prevention MRNA Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of mRNA Vaccines & Therapeutics for each application, including

• Application 1
• Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) mRNA Vaccines & Therapeutics Market Report 2017

1 MRNA VACCINES & THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 Classification of mRNA Vaccines & Therapeutics
  1.2.1 EMEA mRNA Vaccines & Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA mRNA Vaccines & Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Standardization Of Cancer Treatment MRNA Vaccine
  1.2.4 Individualized Cancer Treatment MRNA Vaccine
  1.2.5 Infectious Disease Treatment MRNA Vaccine
  1.2.6 Infection Prevention MRNA Vaccine
1.3 EMEA mRNA Vaccines & Therapeutics Market by Application/End Users
  1.3.1 EMEA mRNA Vaccines & Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.1 Application
  1.3.2 Application
1.4 EMEA mRNA Vaccines & Therapeutics Market by Region
  1.4.1 EMEA mRNA Vaccines & Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of mRNA Vaccines & Therapeutics (2012-2022)
  1.5.1 EMEA mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 EMEA mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2022)

2 EMEA MRNA VACCINES & THERAPEUTICS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA mRNA Vaccines & Therapeutics Market Competition by Players/Manufacturers
  2.1.1 EMEA mRNA Vaccines & Therapeutics Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA mRNA Vaccines & Therapeutics Revenue and Share by Players (2012-2017)
  2.1.3 EMEA mRNA Vaccines & Therapeutics Sale Price by Players (2012-2017)
2.2 EMEA mRNA Vaccines & Therapeutics (Volume and Value) by Type/Product Category
  2.2.1 EMEA mRNA Vaccines & Therapeutics Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA mRNA Vaccines & Therapeutics Sale Price by Type (2012-2017)
2.3 EMEA mRNA Vaccines & Therapeutics (Volume) by Application
2.4 EMEA mRNA Vaccines & Therapeutics (Volume and Value) by Region
  2.4.1 EMEA mRNA Vaccines & Therapeutics Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA mRNA Vaccines & Therapeutics Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA mRNA Vaccines & Therapeutics Sales Price by Region (2012-2017)

3 EUROPE MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  3.1.1 Europe mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
3.2 Europe mRNA Vaccines & Therapeutics Sales and Market Share by Type
3.3 Europe mRNA Vaccines & Therapeutics Sales and Market Share by Application
3.4 Europe mRNA Vaccines & Therapeutics Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe mRNA Vaccines & Therapeutics Sales Volume by Countries (2012-2017)
  3.4.2 Europe mRNA Vaccines & Therapeutics Revenue by Countries (2012-2017)
  3.4.3 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  3.4.4 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  3.4.5 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  3.4.6 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  3.4.7 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  3.4.8 Benelux mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)

4 MIDDLE EAST MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  4.1.1 Middle East mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
4.2 Middle East mRNA Vaccines & Therapeutics Sales and Market Share by Type
4.3 Middle East mRNA Vaccines & Therapeutics Sales and Market Share by Application
4.4 Middle East mRNA Vaccines & Therapeutics Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East mRNA Vaccines & Therapeutics Sales Volume by Countries (2012-2017)
  4.4.2 Middle East mRNA Vaccines & Therapeutics Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  4.4.4 Israel mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  4.4.5 UAE mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  4.4.6 Iran mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)

5 AFRICA MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  5.1.1 Africa mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
5.2 Africa mRNA Vaccines & Therapeutics Sales and Market Share by Type
5.3 Africa mRNA Vaccines & Therapeutics Sales and Market Share by Application
5.4 Africa mRNA Vaccines & Therapeutics Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa mRNA Vaccines & Therapeutics Sales Volume by Countries (2012-2017)
  5.4.2 Africa mRNA Vaccines & Therapeutics Revenue by Countries (2012-2017)
  5.4.3 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  5.4.5 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)
  5.4.6 Algeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2017)

6 EMEA MRNA VACCINES & THERAPEUTICS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Argos Therapeutics
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bayer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 BioNTech
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Boehringer Ingelheim
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 CRISPR Therapeutics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 CureVac
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 eTheRNA immunotherapies
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Ethris
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline Vaccines
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 mRNA Vaccines & Therapeutics Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 In-Cell-Art
6.12 Intellia Therapeutics
6.13 Janssen
6.14 Kernal Biologics
6.15 MaxCyte
6.16 Moderna Therapeutics
6.17 Novartis
6.18 PhaseRx
6.19 Precision NanoSystems
6.20 RaNa Therapeutics

7 MRNA VACCINES & THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 mRNA Vaccines & Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of mRNA Vaccines & Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA MRNA VACCINES & THERAPEUTICS MARKET FORECAST (2017-2022)

11.1 EMEA mRNA Vaccines & Therapeutics Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA mRNA Vaccines & Therapeutics Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA mRNA Vaccines & Therapeutics Price and Trend Forecast (2017-2022)
11.2 EMEA mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA mRNA Vaccines & Therapeutics Sales Forecast by Type (2017-2022)
11.7 EMEA mRNA Vaccines & Therapeutics Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of mRNA Vaccines & Therapeutics
Figure EMEA mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2022)
Figure EMEA mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Standardization Of Cancer Treatment MRNA Vaccine Product Picture
Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
Figure Infectious Disease Treatment MRNA Vaccine Product Picture
Figure Infection Prevention MRNA Vaccine Product Picture
Figure EMEA mRNA Vaccines & Therapeutics Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of mRNA Vaccines & Therapeutics by Application in 2016
Figure Application 1 Examples
Table Key Downstream Customer in Application
Figure Application 2 Examples
Table Key Downstream Customer in Application
Figure EMEA mRNA Vaccines & Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure Europe mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe mRNA Vaccines & Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East mRNA Vaccines & Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure Africa mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa mRNA Vaccines & Therapeutics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2022)
Figure EMEA mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA mRNA Vaccines & Therapeutics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Sales Share by Players (2012-2017)
Figure 2016 mRNA Vaccines & Therapeutics Sales Share by Players
Figure 2017 mRNA Vaccines & Therapeutics Sales Share by Players
Figure EMEA mRNA Vaccines & Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Revenue (Million USD) by Players (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Revenue Share by Players (2012-2017)
Table 2016 EMEA mRNA Vaccines & Therapeutics Revenue Share by Players
Table 2017 EMEA mRNA Vaccines & Therapeutics Revenue Share by Players
Table EMEA mRNA Vaccines & Therapeutics Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Sales Share by Type (2012-2017)
Figure Sales Market Share of mRNA Vaccines & Therapeutics by Type (2012-2017)
Figure EMEA mRNA Vaccines & Therapeutics Sales Market Share by Type (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Type in 2016
Table EMEA mRNA Vaccines & Therapeutics Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Sales Share by Application (2012-2017)
Figure Sales Market Share of mRNA Vaccines & Therapeutics by Application (2012-2017)
Figure EMEA mRNA Vaccines & Therapeutics Sales Market Share by Application in 2016
Table EMEA mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Sales Share by Region (2012-2017)
Figure Sales Market Share of mRNA Vaccines & Therapeutics by Region (2012-2017)
Figure EMEA mRNA Vaccines & Therapeutics Sales Market Share in 2016
Table EMEA mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA mRNA Vaccines & Therapeutics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Region (2012-2017)
Figure EMEA mRNA Vaccines & Therapeutics Revenue Market Share Regions in 2016
Table EMEA mRNA Vaccines & Therapeutics Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
Table Europe mRNA Vaccines & Therapeutics Sales (K Units) by Type (2012-2017)
Table Europe mRNA Vaccines & Therapeutics Market Share by Type (2012-2017)
Figure Europe mRNA Vaccines & Therapeutics Market Share by Type in 2016
Table Europe mRNA Vaccines & Therapeutics Sales (K Units) by Application (2012-2017)
Table Europe mRNA Vaccines & Therapeutics Market Share by Application (2012-2017)
Figure Europe mRNA Vaccines & Therapeutics Market Share by Application in 2016
Table Europe mRNA Vaccines & Therapeutics Sales (K Units) by Countries (2012-2017)
Table Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2012-2017)
Figure Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2012-2017)
Figure Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2016
Table Europe mRNA Vaccines & Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2016
Figure Germany mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure France mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure UK mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Russia mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Italy mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East mRNA Vaccines & Therapeutics Sales (K Units) by Type (2012-2017)
Table Middle East mRNA Vaccines & Therapeutics Market Share by Type (2012-2017)
Figure Middle East mRNA Vaccines & Therapeutics Market Share by Type (2012-2017)
Table Middle East mRNA Vaccines & Therapeutics Sales (K Units) by Applications (2012-2017)
Table Middle East mRNA Vaccines & Therapeutics Market Share by Applications (2012-2017)
Figure Middle East mRNA Vaccines & Therapeutics Sales Market Share by Application in 2016
Table Middle East mRNA Vaccines & Therapeutics Sales Volume (K Units) by Countries (2012-2017)
Table Middle East mRNA Vaccines & Therapeutics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East mRNA Vaccines & Therapeutics Sales Volume Market Share by Countries in 2016
Table Middle East mRNA Vaccines & Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Middle East mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Middle East mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Middle East mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2016
Figure Saudi Arabia mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Israel mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure UAE mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Iran mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa mRNA Vaccines & Therapeutics Sales (K Units) by Type (2012-2017)
Table Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2012-2017)
Figure Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2012-2017)
Figure Africa mRNA Vaccines & Therapeutics Sales Market Share by Type in 2016
Table Africa mRNA Vaccines & Therapeutics Sales (K Units) by Application (2012-2017)
Table Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2012-2017)
Figure Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2012-2017)
Table Africa mRNA Vaccines & Therapeutics Sales Volume (K Units) by Countries (2012-2017)
Table Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2012-2017)
Figure Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2012-2017)
Figure Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2016
Table Africa mRNA Vaccines & Therapeutics Revenue (Million USD) by Countries (2012-2017)
Table Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2012-2017)
Figure Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2016
Figure South Africa mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Table Argos Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca mRNA Vaccines & Therapeutics Basic Information List
Table AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Bayer mRNA Vaccines & Therapeutics Basic Information List
Table Bayer mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table BioNTech mRNA Vaccines & Therapeutics Basic Information List
Table BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Basic Information List
Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table CureVac mRNA Vaccines & Therapeutics Basic Information List
Table CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table eTheRNA immunotherapies mRNA Vaccines & Therapeutics Basic Information List
Table eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table Ethris mRNA Vaccines & Therapeutics Basic Information List
Table Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Basic Information List
Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Revenue Market Share in EMEA (2012-2017)
Table In-Cell-Art mRNA Vaccines & Therapeutics Basic Information List
Table Intellia Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Janssen mRNA Vaccines & Therapeutics Basic Information List
Table Kernal Biologics mRNA Vaccines & Therapeutics Basic Information List
Table MaxCyte mRNA Vaccines & Therapeutics Basic Information List
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Novartis mRNA Vaccines & Therapeutics Basic Information List
Table PhaseRx mRNA Vaccines & Therapeutics Basic Information List
Table Precision NanoSystems mRNA Vaccines & Therapeutics Basic Information List
Table RaNa Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure mRNA Vaccines & Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of mRNA Vaccines & Therapeutics Major Manufacturers in 2016
Table Major Buyers of mRNA Vaccines & Therapeutics
Table Distributors/Traders List
Figure EMEA mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA mRNA Vaccines & Therapeutics Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2017-2022)
Table EMEA mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region (2017-2022)
Table Europe mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe mRNA Vaccines & Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Europe mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East mRNA Vaccines & Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa mRNA Vaccines & Therapeutics Sales Market Share Forecast by Countries (2017-2022)
Table Africa mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2017-2022)
Table EMEA mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources